Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
R56 AI118791
NIAID NIH HHS - United States
DC0190GP
CIHR - Canada
P01 HL076383
NHLBI NIH HHS - United States
R01 AI132590
NIAID NIH HHS - United States
U19 AI070235
NIAID NIH HHS - United States
F32 DC000190
NIDCD NIH HHS - United States
R01 AI127644
NIAID NIH HHS - United States
T32 ES007141
NIEHS NIH HHS - United States
R01 AI083315
NIAID NIH HHS - United States
PubMed
32572240
PubMed Central
PMC9291269
DOI
10.1038/s41590-020-0698-1
PII: 10.1038/s41590-020-0698-1
Knihovny.cz E-resources
- MeSH
- Allergens immunology MeSH
- Rhinitis, Allergic immunology pathology MeSH
- Antigens, Dermatophagoides immunology MeSH
- Asthma immunology pathology MeSH
- Adult MeSH
- Epithelial Cells MeSH
- Immunity, Humoral MeSH
- Interleukin-33 metabolism MeSH
- Cells, Cultured MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Disease Models, Animal MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Lung cytology immunology pathology MeSH
- Primary Cell Culture MeSH
- Immunity, Innate MeSH
- Fatty Acid-Binding Proteins immunology MeSH
- Receptors, Lipoxin metabolism MeSH
- Receptors, Formyl Peptide metabolism MeSH
- Respiratory Mucosa immunology metabolism MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Serum Amyloid A Protein genetics metabolism MeSH
- Signal Transduction immunology MeSH
- Up-Regulation MeSH
- Animals MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Mice MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
- Names of Substances
- Allergens MeSH
- Antigens, Dermatophagoides MeSH
- formyl peptide receptor 2, mouse MeSH Browser
- FPR2 protein, human MeSH Browser
- IL33 protein, human MeSH Browser
- Il33 protein, mouse MeSH Browser
- Interleukin-33 MeSH
- Fatty Acid-Binding Proteins MeSH
- Receptors, Lipoxin MeSH
- Receptors, Formyl Peptide MeSH
- SAA1 protein, human MeSH Browser
- Saa2 protein, mouse MeSH Browser
- Serum Amyloid A Protein MeSH
The molecular basis for the propensity of a small number of environmental proteins to provoke allergic responses is largely unknown. Herein, we report that mite group 13 allergens of the fatty acid-binding protein (FABP) family are sensed by an evolutionarily conserved acute-phase protein, serum amyloid A1 (SAA1), that promotes pulmonary type 2 immunity. Mechanistically, SAA1 interacted directly with allergenic mite FABPs (Der p 13 and Blo t 13). The interaction between mite FABPs and SAA1 activated the SAA1-binding receptor, formyl peptide receptor 2 (FPR2), which drove the epithelial release of the type-2-promoting cytokine interleukin (IL)-33 in a SAA1-dependent manner. Importantly, the SAA1-FPR2-IL-33 axis was upregulated in nasal epithelial cells from patients with chronic rhinosinusitis. These findings identify an unrecognized role for SAA1 as a soluble pattern recognition receptor for conserved FABPs found in common mite allergens that initiate type 2 immunity at mucosal surfaces.
Institute for Immunological Research University of Cartagena Cartagena Colombia
Institute of Molecular Biosciences BioTechMed Graz University of Graz Graz Austria
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
Institute of Specific Prophylaxis and Tropical Medicine Medical University of Vienna Vienna Austria
See more in PubMed
Wills-Karp M, Nathan A, Page K & Karp CL New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol 3, 104–110 (2010). PubMed PMC
Corrigan CJ et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J. Allergy Clin. Immunol 128, 116–124 (2011). PubMed
Gour N et al. Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases. Sci Immunol 3 (20): eaam9841 (2018). PubMed PMC
Schuijs MJ et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349, 1106–1110 (2015). PubMed
Smole U, Kratzer B & Pickl WF Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfaces. Eur. J. Immunol 50, 624–642 (2020). PubMed PMC
Urieli-Shoval S, Cohen P, Eisenberg S & Matzner Y Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem 46, 1377–1384 (1998). PubMed
Malle E, Sodin-Semrl S & Kovacevic A Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell. Mol. Life Sci 66, 9–26 (2009). PubMed PMC
Cai Z et al. Human serum amyloid A protein inhibits hepatitis C virus entry into cells. J. Virol 81, 6128–6133 (2007). PubMed PMC
Shah C, Hari-Dass R & Raynes JG Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108, 1751–1757 (2006). PubMed
de Beer MC et al. Impact of serum amyloid A on high density lipoprotein composition and levels. J. Lipid Res 51, 3117–3125 (2010). PubMed PMC
Hinrichs BH et al. Serum Amyloid A1 Is an Epithelial Prorestitutive Factor. Am. J. Pathol 188, 937–949 (2018). PubMed PMC
Sun L & Ye RD Serum amyloid A1: Structure, function and gene polymorphism. Gene 583, 48–57 (2016). PubMed PMC
Cheng N, Liang Y, Du X & Ye RD Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep 19 (10): e45517, (2018). PubMed PMC
Kim MH, de Beer MC, Wroblewski JM, Webb NR & de Beer FC SAA does not induce cytokine production in physiological conditions. Cytokine 61, 506–512 (2013). PubMed PMC
Lu J, Yu Y, Zhu I, Cheng Y & Sun PD Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc. Natl. Acad. Sci. U. S. A 111, 5189–5194 (2014). PubMed PMC
Wang Y et al. Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer. Biochem. Biophys. Res. Commun 407, 725–729 (2011). PubMed PMC
Sano T et al. An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses. Cell 163, 381–393 (2015). PubMed PMC
Ather JL et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J. Immunol 187, 64–73 (2011). PubMed PMC
Buyukozturk S et al. Acute phase reactants in allergic airway disease. Tohoku J. Exp. Med 204, 209–213 (2004). PubMed
Jousilahti P et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann. Allergy. Asthma. Immunol 89, 381–385 (2002). PubMed
Ozseker F et al. Serum amyloid A (SAA) in induced sputum of asthmatics: a new look to an old marker. Int Immunopharmacol 6, 1569–1576 (2006). PubMed
Ricklefs I et al. ALX receptor ligands define a biochemical endotype for severe asthma. JCI Insight 2 (14): e93534. (2017). PubMed PMC
Lambrecht BN, Hammad H & Fahy JV The Cytokines of Asthma. Immunity 50, 975–991 (2019). PubMed
Cayrol C et al. Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat Immunol 19, 375–385 (2018). PubMed
Gold MJ et al. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J. Allergy Clin. Immunol 133, 1142–1148 (2014). PubMed
Halim TY et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425–435 (2014). PubMed PMC
Ather JL et al. Serum Amyloid A3 is required for normal lung development and survival following influenza infection. Sci Rep 8, 16571 (2018). PubMed PMC
Pautsch A & Schulz GE High-resolution structure of the OmpA membrane domain. J. Mol. Biol 298, 273–282 (2000). PubMed
Niemi MH et al. Dimerization of lipocalin allergens. Sci Rep 5, 13841 (2015). PubMed PMC
Malle E et al. Mapping of antigenic determinants of purified, lipid-free human serum amyloid A proteins. Scand. J. Immunol 48, 557–561 (1998). PubMed
Suojalehto H et al. Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation. PLoS One 10, e0127003 (2015). PubMed PMC
Thaumaturgo N, Vilar MM, Diogo CM, Edelenyi R & Tendler M Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract. Mem. Inst. Oswaldo Cruz 96 Suppl, 79–83 (2001). PubMed
Franchini GR et al. The unusual lipid binding proteins of parasitic helminths and their potential roles in parasitism and as therapeutic targets. Prostaglandins Leukot. Essent. Fatty Acids 93, 31–36 (2015). PubMed
Derebe MG et al. Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection. Elife 3, e03206 (2014). PubMed PMC
Zhou H, Chen M, Zhang G & Ye RD Suppression of Lipopolysaccharide-Induced Inflammatory Response by Fragments from Serum Amyloid A. J. Immunol 199, 1105–1112 (2017). PubMed
Rabiet MJ, Macari L, Dahlgren C & Boulay F N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation. J. Biol. Chem 286, 26718–26731 (2011). PubMed PMC
Cooray SN et al. Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc. Natl. Acad. Sci. U. S. A 110, 18232–18237 (2013). PubMed PMC
Snelgrove RJ et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J. Allergy Clin. Immunol 134, 583–592 (2014). PubMed PMC
Green BJ et al. Allergic sensitization in Canadian chronic rhinosinusitis patients. Allergy Asthma Clin Immunol 10, 15 (2014). PubMed PMC
Chu DK et al. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J. Allergy Clin. Immunol 131, 187–200 (2013). PubMed
Rank MA et al. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol 123, 1047–1054 (2009). PubMed PMC
Besnard AG et al. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol 41, 1675–1686 (2011). PubMed
Frame NM, Jayaraman S, Gantz DL & Gursky O Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a “molecular mop” in immune response. J. Struct. Biol 200, 293–302 (2017). PubMed PMC
Jayaraman S, Gantz DL, Haupt C & Gursky O Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis. Proc. Natl. Acad. Sci. U. S. A 114, E6507–E6515 (2017). PubMed PMC
Bjorkman L et al. The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation. Arthritis Rheum 62, 1660–1665 (2010). PubMed
Christenson K et al. Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors. Front Immunol 4, 92 (2013). PubMed PMC
Puerta L, Kennedy MW, Jim nez S & Caraballo L Structural and ligand binding analysis of recombinant blo t 13 allergen from Blomia tropicalis mite, a fatty acid binding protein. Int. Arch. Allergy Immunol 119, 181–184 (1999). PubMed
Scott IC et al. Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage. Sci Rep 8, 3363 (2018). PubMed PMC
Ivanov II et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498 (2009). PubMed PMC
Caraballo L et al. Cloning and IgE binding of a recombinant allergen from the mite Blomia tropicalis, homologous with fatty acid-binding proteins. Int. Arch. Allergy Immunol 112, 341–347 (1997). PubMed
Zimmerman AW & Veerkamp JH New insights into the structure and function of fatty acid-binding proteins. Cell. Mol. Life Sci 59, 1096–1116 (2002). PubMed PMC
Miljkovic D et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 69, 1154–1161 (2014). PubMed
Shaw JL et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am. J. Respir. Crit. Care Med 188, 432–439 (2013). PubMed PMC
Chen M, Zhou H, Cheng N, Qian F & Ye RD Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. Immunobiology 219, 916–923 (2014). PubMed PMC
Lotvall J et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol 127, 355–360 (2011). PubMed
Leontovyc A et al. SmSP2: A serine protease secreted by the blood fluke pathogen Schistosoma mansoni with anti-hemostatic properties. PLoS Negl Trop Dis 12, e0006446 (2018). PubMed PMC
Lajoie S et al. IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses. Clin. Exp. Allergy 44, 976–985 (2014). PubMed PMC
Paris G, Pozharskaya T, Asempa T & Lane AP Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells. Int Forum Allergy Rhinol 4, 15–21 (2014). PubMed PMC
Darveau ME, Jacques E, Rouabhia M, Hamid Q & Chakir J Increased T-cell survival by structural bronchial cells derived from asthmatic subjects cultured in an engineered human mucosa. J. Allergy Clin. Immunol 121, 692–699 (2008). PubMed
Goulet F et al. Morphologic and functional properties of bronchial cells isolated from normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol 15, 312–318 (1996). PubMed
Labrada M et al. Monoclonal antibodies against Blo t 13, a recombinant allergen from Blomia tropicalis. Int. Arch. Allergy Immunol 129, 212–218 (2002). PubMed
Kratzer B et al. Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model. Allergy 74, 246–260 (2019). PubMed PMC